methotrexate has been researched along with Carcinoma, Ductal, Breast in 77 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 26 (33.77) | 18.2507 |
| 2000's | 31 (40.26) | 29.6817 |
| 2010's | 20 (25.97) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antognelli, C; Crinò, L; Eliana, R; Floriani, I; Foglietta, J; Gori, S; Ludovini, V; Minenza, E; Nocentini, G; Piattoni, S; Pistola, L; Rulli, A; Sidoni, A; Talesa, VN; Tofanetti, FR; Tonato, M | 1 |
| Barba, M; Del Medico, P; Di Lauro, L; Giannarelli, D; Laudadio, L; Maugeri-Saccà, M; Pizzuti, L; Sergi, D; Tomao, S; Vici, P | 1 |
| Kaczmarczyk, J; Kaczmarek, K; Kubaszewski, Ł; Nowakowski, A; Sulewski, A; Wiącek, MP | 1 |
| Ameye, L; Bozovic-Spasojevic, I; de Azambuja, E; Di Leo, A; Dolci, S; Larsimont, D; Loi, S; Paesmans, M; Piccart, M | 1 |
| Murawska, M; Niwińska, A; Rudnicka, H | 1 |
| Aurilio, G; Bagnardi, V; Curigliano, G; Goldhirsch, A; Graffeo, R; Iera, M; Locatelli, M; Martella, S; Munzone, E; Nolè, F; Petit, JY; Rey, P; Rotmensz, N | 1 |
| Barni, S; Botti, G; Colantuoni, G; D'Aiuto, M; Daniele, B; Daniele, G; De Laurentiis, M; De Maio, E; de Matteis, A; De Placido, S; Di Maio, M; Di Rella, F; Forestieri, V; Gallo, C; Gori, S; Gravina, A; Iodice, G; Labonia, V; Landi, G; Lauria, R; Montanino, A; Morabito, A; Nuzzo, F; Pacilio, C; Perrone, F; Piccirillo, MC; Riccardi, F; Rossi, E; Signoriello, S; Tinessa, V | 1 |
| Al-Hameed, FM | 1 |
| Park, MJ | 1 |
| Broggini, M; Cavalli, IJ; Chilà, R; Damia, G; de Lima, RS; de Oliveira, SF; Ganzinelli, M; Generali, D; Maciel, ME; Ribeiro, EM; Serino, L; Urban, Cde A | 1 |
| Ahmed, SI; Aleskandarany, MA; Chan, S; Ellis, IO; Elsheikh, SE; Green, AR; Macmillan, RD; Mohammed, RA; Paish, EC; Powe, DG; Rakha, EA | 1 |
| Bianchi, S; Biti, GP; Borghesi, S; Cataliotti, L; De Luca Cardillo, C; Greto, D; Livi, L; Mangoni, M; Paiar, F; Saieva, C; Scotti, V | 1 |
| Dittmer, A; Dittmer, J; Holzhausen, HJ; Kantelhardt, E; Ronneburg, H; Schunke, D; Span, PN; Sweep, FC | 1 |
| Accorsi, P; Candeloro, G; Necozione, S; Rea, S; Recchia, CO; Recchia, F; Tombolini, V | 1 |
| Bidard, FC; Cottu, PH; Diéras, V; Gauthier, H; Girre, V; Guilhaume, MN; Laurence, V; Livartowski, A; Mignot, L; Pierga, JY | 1 |
| Chung, HC; Hong, S; Jeung, HC; Jung, M; Kim, HS; Moon, YW; Oh, KJ; Rha, SY; Roh, JK; Shin, HJ; Yang, WI | 1 |
| Arriagada, R; Bourgier, C; Dunant, A; Heymann, S; Marsiglia, H; Mathieu, MC; Pessoa, EL; Spielmann, M; Uzan, C | 1 |
| Bando, H; Iwata, H; Kashiwaba, M; Mizuno, T; Murakami, S; Nakayama, T; Ohashi, Y; Sawaki, M; Taira, N; Tokudome, N; Uemura, Y; Yamamoto, Y | 1 |
| Baak, JP; Gilje, B; Janssen, EA; Nordgård, O; Smaaland, R; Søiland, H; Tjensvoll, K | 1 |
| Bestul, D; Corbets, L; Martens, J; Venuturumilli, P | 1 |
| Berrino, F; Bruno, E; Curtosi, P; Evangelista, A; Gargano, G; Morelli, D; Pasanisi, P; Raimondi, M; Villarini, A | 1 |
| Carrara, HH; Silva, LM; Takahashi, CS | 1 |
| Arcuri, MF; Corcione, L; Del Rio, P; Sivelli, R | 1 |
| Benito, E; Escobedo, A; Gumà, A; Moreno, A; Riu, F; Serra, JM | 1 |
| Jaffe, BM; Kahn, MJ; Weldon, CB | 1 |
| Bertsch, H; Fox, K; Glick, J; Harris, EE; Schultz, D; Solin, LJ | 1 |
| Blondeel, PN; Cocquyt, VF; Daems, KK; Depypere, HT; Hurley, J; Praet, MM; Schelfhout, VR; Serreyn, RF; Silva, OE; Van Belle, SJ | 1 |
| Fridrik, M; Gnant, M; Haider, K; Hausmaninger, H; Jakesz, R; Kolb, R; Kubista, E; Mlineritsch, B; Ploner, F; Samonigg, H; Seifert, M; Steger, G; Steindorfer, P; Stierer, M; Tschurtschenthaler, G | 1 |
| Chen, CA; Chen, M | 1 |
| Coebergh, JW; Ernst, MF; Poortmans, PM; Roukema, JA; Voogd, AC | 1 |
| Ooi, Y; Rai, Y; Sagara, Y | 1 |
| Abe, H; Endo, Y; Hanasawa, K; Kushima, R; Naitoh, H; Tani, T | 1 |
| Basso, U; Brunello, A; Ghiotto, C; Iacobone, M; Jirillo, A; Koussis, H; Lumachi, F; Monfardini, S; Pogliani, C; Vamvakas, L | 1 |
| Cold, S; Düring, M; Ewertz, M; Knoop, A; Møller, S | 1 |
| Feng, FY; He, J; Wang, XY; Xing, PY; Zhang, P | 1 |
| Bae, JY; Bae, YJ; Han, MR; Han, W; Hwang, KT; Hwang, SE; Kang, JJ; Kim, SW; Lee, JE; Lee, JH; Noh, DY; Shin, HJ | 1 |
| Bafaloukos, D; Bourli, A; Christodoulou, C; Dafni, U; Fillipidis, T; Fountzilas, G; Gogas, H; Kafiri, G; Karagianni, E; Kyriakou, V; Malamou-Mitsi, V; Markaki, S; Papadopoulos, S; Papakostas, P; Papaspyrou, I; Pavlakis, K; Scopa, C; Sotiropoulou, M; Toliou, T; Tzaida, O; Vlachodimitropoulos, D | 1 |
| Carrato Mena, A; Guillén Ponce, C; Maciá Escalante, S; Martínez Banaclocha, N; Pons Sanz, V; Rodríguez Lescure, A | 1 |
| Amaddeo, P; Barbaglio, A; Faldi, F; Fontana, S; Ghilardi, R; Pericotti, S | 1 |
| Cymek, S; Kanczuga-Koda, L; Koda, M; Kucharczuk, W; Lesniewicz, T; Sulkowska, M; Sulkowski, S; Tomaszewski, J | 1 |
| Chao, TY; Chiang, YH; Lin, CS; Lin, SH; Sheu, LF | 1 |
| Chen, L; Fan, Y; Fu, L; Guo, XJ; Lang, RG; Sun, YL | 1 |
| Guo, XT; Liu, WC; Xue, Y | 1 |
| Agarwal, JP; Gupta, T; Jain, S; Menon, H; Mistry, RC; Parikh, PM; Pramesh, CS; Shrivastava, SK | 1 |
| Eiermann, W; Harbeck, N; Pache, L; Untch, M | 1 |
| Demetri, GD; Kaplan, WD; Salgia, R | 1 |
| Brockerhoff, P; Casper, F; Hofmann, M; Mahlke, M | 1 |
| Dimitrov, N; Grundfest-Broniatowski, S; Lerner, HJ; Margolese, RG; Prager, D; Silverman, P | 1 |
| Dufour, P; Hild, P; Korganov, AS; Maloisel, F; Oberling, F; Petit, T | 1 |
| Kunii, Y; Nitta, A; Ota, K; Takahashi, N | 1 |
| Fechner, RE; Frierson, HF | 1 |
| Khairallah, S; Lattouf, AN; Saadé, M | 1 |
| Chen, JA | 1 |
| Gupta, D; Muralikrishna, BV; Singh, DP; Singh, G | 1 |
| Guy, RL; Husband, JE; Knee, G; MacVicar, AD; Powles, TJ; Sloane, JP; Vinnicombe, SJ | 1 |
| Adler, DD; Cody, RL; Helvie, MA; Joynt, LK; Merajver, SD; Pierce, LJ | 1 |
| Arriagada, R; Fontaine, F; Le Chevalier, T; Mouriesse, H; Spielmann, M; Thomas, F; Tursz, T | 1 |
| DiPaola, RS; Kaufman, A; Mikhail, MM | 1 |
| Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Iwanaga, T; Kabuto, T; Kameyama, M; Nakamori, S; Nakano, H; Ohigashi, H; Sasaki, Y; Tsuji, Y; Yasuda, T | 1 |
| Bünemann, H; Heilmann, HP; Janik, I; Willers, H; Würschmidt, F | 1 |
| De Filippis, S; Lalli, A; Nuzzo, A; Recchia, F; Torchio, P | 1 |
| Dufour, P; Korganov, AS; Maloisel, F; Oberling, F; Petit, T | 1 |
| Annegers, JF; Buzdar, AU; Dhingra, K; Frankowski, RF; Frye, DK; Hortobagyi, GN; Kinney, AY; Sahin, A; Vernon, SW | 1 |
| Emanuel, EJ; Patterson, WB | 1 |
| Fowble, B; Freedman, G; Goldstein, LJ; Hanlon, AL; Hoffman, JP; Patchefsky, A; Sigurdson, ER | 1 |
| Coshic, O; Govindaraju, V; Jagannathan, NR; Julka, PK; Raghunathan, P; Rath, GK; Singh, M | 1 |
| Han, S; Kim, HJ; Kim, HY; Kim, YD; Lee, MS; Park, K | 1 |
| Aoki, J; Fujita, M; Hino, N; Miyagawa, H; Nakagawa, H; Sasaki, N; Taniyama, K; Uno, H | 1 |
| Crabo, L; Hall, TC; Shokeir, MO; Taylor, MA; Wreggit, GR | 1 |
| Churn, M; Davies, C; Slater, A | 1 |
| Amir, C; Arthur, DW; Bear, HD; Friedman, RB; Hackney, MH; Kachnic, LA; Lawrence, W; Schmidt-Ullrich, RK; Smith, TJ; Wazer, DE | 1 |
| Ansaloni, L; Bazzocchi, R; Bini, A; Grazia, M; Stella, F; Zompatori, M | 1 |
| Antonopoulos, M; Kosmas, C; Malamos, NA; Tsavaris, N | 1 |
| Biganzoli, E; Bonoldi, E; Boracchi, P; Fanelli, M; Gasparini, G; Morabito, A | 1 |
| Coupek, P; Filip, S; Petera, J; Slampa, P; Soumarová, R; Zatloukal, P | 1 |
| Barbareschi, M; Caffo, O; Dalla Palma, P; Galligioni, E; Kakudo, K; Mauri, F; Mori, I; Muscarà, M; Nakamura, M; Nakamura, Y; Sakurai, T; Yang, Q; Yoshimura, G | 1 |
| Eifrig, B; Hegewisch-Becker, S; Hossfeld, DK; Langer, F; Marx, G; Neuber, K | 1 |
8 review(s) available for methotrexate and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Durable Response of Leptomeningeal Metastasis of Breast Cancer to Salvage Intrathecal Etoposide After Methotrexate: A Case Report and Literature Review.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Etoposide; Female; Humans; Injections, Spinal; Meningeal Neoplasms; Methotrexate; Salvage Therapy | 2015 |
Ten-year outcome after combined modality therapy for inflammatory breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Life Tables; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pennsylvania; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome | 2003 |
Invasive ductal carcinoma within a fibroadenoma of the breast.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Female; Fibroadenoma; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Treatment Outcome | 2004 |
[Clinical research advancement on male breast cancer].
Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis Regulatory Proteins; BRCA2 Protein; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cisplatin; Fluorouracil; Humans; Male; Mastectomy; Methotrexate; Neoplasm Staging; Tamoxifen | 2007 |
Case report: Second primary small cell carcinoma of the trachea in a breast cancer survivor: a case report and literature review.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy, Modified Radical; Methotrexate; Neoplasms, Second Primary; Positron-Emission Tomography; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Tracheal Neoplasms; Treatment Outcome | 2008 |
Synchronous bilateral carcinoma of the breasts occurring in a young woman with a history of Langerhans' cell histiocytosis in infancy.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Chronic Disease; Female; Histiocytosis, Langerhans-Cell; Humans; Methotrexate; Neoplasms, Multiple Primary; Prednisolone; Vinblastine | 1999 |
Bilateral recurrent pneumothorax complicating chemotherapy for pulmonary metastatic breast ductal carcinoma: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Drainage; Female; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Pneumothorax; Recurrence; Treatment Outcome | 2000 |
Chemotherapy-induced complete regression of choroidal metastases and subsequent isolated leptomeningeal carcinomatosis in advanced breast cancer: a case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Choroid Neoplasms; Combined Modality Therapy; Docetaxel; Female; Humans; Meningeal Neoplasms; Methotrexate; Mitoxantrone; Paclitaxel; Survival Analysis; Taxoids | 2000 |
16 trial(s) available for methotrexate and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Taxoids | 2015 |
Prolonged disease control after myeloablative chemotherapy, autologous transplantation and immunotherapy in high-risk early breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; CD4-CD8 Ratio; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-2; Killer Cells, Natural; Methotrexate; Middle Aged; Neoplasm Staging; Prospective Studies; Treatment Outcome; Tretinoin | 2010 |
Survival of breast cancer patients with meningeal carcinomatosis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Leucovorin; Meningeal Carcinomatosis; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Survival Rate; Vitamin B Complex | 2010 |
Evaluation of trastuzumab without chemotherapy as a post-operative adjuvant therapy in HER2-positive elderly breast cancer patients: randomized controlled trial [RESPECT (N-SAS BC07)].
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorouracil; Health Status; Humans; Kaplan-Meier Estimate; Methotrexate; Paclitaxel; Prospective Studies; Quality of Life; Receptor, ErbB-2; Taxoids; Trastuzumab; Treatment Outcome | 2011 |
Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cisplatin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitotic Index; Neoplasm Micrometastasis; Prognosis; Tamoxifen; Treatment Outcome | 2011 |
Preventing weight gain during adjuvant chemotherapy for breast cancer: a dietary intervention study.
Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Diet, Macrobiotic; Diet, Mediterranean; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Overweight; Taxoids; Treatment Outcome; Weight Gain | 2012 |
Pathologic changes related to CMF primary chemotherapy in breast cancer. Pathological evaluation of response predicts clinical outcome.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Disease-Free Survival; Female; Fibrosis; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mammography; Methotrexate; Middle Aged; Neoplasm Staging; Remission Induction; Survival Rate | 2002 |
Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Vincristine | 2003 |
Adjuvant chemotherapy for elderly patients (> or =70 years) with early high-risk breast cancer: a retrospective analysis of 260 patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Nodes; Methotrexate; Middle Aged; Neoplasm Staging; Postmenopause; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Risk Factors; Survival Rate | 2005 |
Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG).
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Prognosis; Stereoisomerism; Survival Rate; Time Factors | 2005 |
Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Gene Expression; Humans; Methotrexate; Middle Aged; Molecular Diagnostic Techniques; Paclitaxel; Predictive Value of Tests; Prognosis; Proto-Oncogene Proteins c-bcl-2; Survival Analysis; Tumor Suppressor Protein p53 | 2006 |
[Clinical study of ambulatory cancer chemotherapy for recurrent breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Female; Fluorouracil; Home Care Services, Hospital-Based; Home Infusion Therapy; Humans; Infusions, Intravenous; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1994 |
[Comparison of the therapeutic effect of CMxMF and CAMF regimens in the management of advanced breast cancer patients].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitoxantrone | 1993 |
Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Female; Humans; Mammography; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Tamoxifen | 1996 |
Activity of standard-dose carboplatin, cyclophosphamide, and etoposide in patients with metastatic breast cancer with previous exposure to anthracyclines.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Cyclophosphamide; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Retreatment; Survival Rate | 1997 |
The prognostic significance of sialyl-Tn antigen in women treated with breast carcinoma treated with adjuvant chemotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Immunoenzyme Techniques; Leucovorin; Methotrexate; Middle Aged; Prognosis; Vinblastine | 1997 |
53 other study(ies) available for methotrexate and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gene Frequency; Genetic Association Studies; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Kaplan-Meier Estimate; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies | 2017 |
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Estrogen Receptor Modulators; Estrogens; Fluorouracil; Gonadotropin-Releasing Hormone; Goserelin; Humans; Kaplan-Meier Estimate; Letrozole; Male; Mastectomy, Modified Radical; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Progesterone; Radiotherapy, Adjuvant; Tamoxifen; Taxoids; Triazoles | 2013 |
Failure and success in the treatment of breast carcinoma in men: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Back Pain; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Cyclophosphamide; Doxorubicin; Fluorouracil; Fractures, Compression; Humans; Kyphoplasty; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Spinal Fractures; Spinal Neoplasms; Stents; Tamoxifen; Thoracic Vertebrae; Tomography, X-Ray Computed; Treatment Outcome; Vertebroplasty | 2014 |
Prognostic, predictive abilities and concordance of BCL2 and TP53 protein expression in primary breast cancers and axillary lymph-nodes: a retrospective analysis of the Belgian three arm study evaluating anthracycline vs CMF adjuvant chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Lymph Nodes; Methotrexate; Middle Aged; Prognosis; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Treatment Outcome; Tumor Suppressor Protein p53 | 2014 |
Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Drug Administration Routes; Female; Humans; Injections, Spinal; Liposomes; Meningeal Neoplasms; Methotrexate; Middle Aged; Prospective Studies | 2015 |
Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Mammaplasty; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptor, ErbB-2; Retrospective Studies; Survival Rate | 2014 |
Saddle pulmonary embolus and bronchiolitis obliterans with organizing pneumonia develop simultaneously after first cyclophosphamide, methotrexate, 5FU chemotherapy for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Renal Cell; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Female; Fluorouracil; Humans; Kidney Neoplasms; Lymph Node Excision; Mastectomy; Methotrexate; Middle Aged; Neoplasms, Multiple Primary; Nephrectomy; Pulmonary Embolism; Tomography, Spiral Computed; Venous Thrombosis | 2015 |
Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines.
Topics: Adenocarcinoma, Mucinous; Antineoplastic Agents; Azacitidine; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; Estrogen Receptor alpha; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Methotrexate; Organ Specificity; Promoter Regions, Genetic; Purine-Nucleoside Phosphorylase; Receptor, ErbB-2; Receptors, Progesterone; RNA, Small Interfering; Signal Transduction; Triple Negative Breast Neoplasms | 2016 |
Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Lymph Nodes; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Survival Rate; Treatment Outcome | 2010 |
Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome | 2009 |
Rho GDP dissociation inhibitor alpha expression correlates with the outcome of CMF treatment in invasive ductal breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cisplatin; Drug Resistance, Neoplasm; Female; Fluorouracil; Guanine Nucleotide Dissociation Inhibitors; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Methotrexate; Middle Aged; Neoplasm Staging; Reverse Transcriptase Polymerase Chain Reaction; rho-Specific Guanine Nucleotide Dissociation Inhibitors; Risk Factors; Treatment Outcome | 2010 |
The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up.
Topics: Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Premenopause; Survival Rate; Tamoxifen; Treatment Outcome | 2010 |
Exclusive alternating chemotherapy and radiotherapy in nonmetastatic inflammatory breast cancer: 20 years of follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachial Plexus Neuropathies; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fibrosis; Fluorouracil; Follow-Up Studies; Heart; Humans; Inflammatory Breast Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Radiation Pneumonitis; Survival Rate; Tamoxifen; Time Factors; Vincristine | 2012 |
Rapid clinical and radiographic improvement after intrathecal trastuzumab and methotrexate in a patient with HER-2 positive leptomeningeal metastases.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Injections, Spinal; Magnetic Resonance Imaging; Meningeal Carcinomatosis; Methotrexate; Receptor, ErbB-2; Trastuzumab | 2013 |
Study of chromosome damage in patients with breast cancer treated by two antineoplastic treatments.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cell Division; Chromosome Aberrations; Chromosomes, Human; Cyclophosphamide; DNA Damage; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitotic Index; Sister Chromatid Exchange | 2002 |
[Breast carcinoma in accessory gland: a case report].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Methotrexate; Middle Aged; Tamoxifen; Time Factors | 2002 |
Therapy-induced leukemias and myelodysplastic syndromes after breast cancer treatment: an underemphasized clinical problem.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Fatal Outcome; Female; Fluorouracil; Humans; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Tamoxifen | 2002 |
Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Survival Analysis; Treatment Outcome | 2003 |
Simultaneous occurrence of hepatic focal nodular hyperplasia and uterine endometrial stromal nodule in a patient having treated breast infiltrating ductal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Comorbidity; Cyclophosphamide; Endometrial Stromal Tumors; Female; Fluorouracil; Focal Nodular Hyperplasia; Humans; Leiomyoma; Magnetic Resonance Imaging; Methotrexate; Neoplasms, Multiple Primary; Uterine Neoplasms | 2003 |
Using loco-regional recurrence as an indicator of the quality of breast cancer treatment.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 2004 |
[Two cases of breast cancer markedly responded to neoadjuvant chemoendocrine therapy (2 cycles of CMF and tamoxifen, pCR and near pCR)].
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Mastectomy, Segmental; Methotrexate; Neoadjuvant Therapy; Remission Induction; Tamoxifen | 2004 |
[Clinical analysis of 67 patients with brain metastases from breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cranial Irradiation; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Survival Rate | 2005 |
Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Chromosomes, Artificial, Bacterial; Cluster Analysis; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; DNA, Neoplasm; Estrogen Receptor Modulators; Estrogens; Female; Fluorouracil; Humans; Life Tables; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Prognosis; Radiotherapy, Adjuvant; Receptors, Estrogen; Tamoxifen | 2006 |
A patient with breast cancer with hepatic metastases and a complete response to herceptin as monotherapy.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Karnofsky Performance Status; Liver Neoplasms; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Radiotherapy Dosage; Receptor, ErbB-2; Tamoxifen; Time Factors; Tomography, X-Ray Computed; Trastuzumab; Treatment Outcome | 2006 |
Male breast cancer with mandibular metastasis. A case report.
Topics: Aged; Androstadienes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Cortisone; Cyclophosphamide; Diphosphonates; Docetaxel; Fatal Outcome; Fluorouracil; Furosemide; Humans; Imidazoles; Liver Neoplasms; Male; Mandibular Neoplasms; Mastectomy, Modified Radical; Methotrexate; Omeprazole; Osteolysis; Phenobarbital; Taxoids; Toremifene; Vinblastine; Vinorelbine; Zoledronic Acid | 2007 |
The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; bcl-2 Homologous Antagonist-Killer Protein; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Female; Fluorouracil; Humans; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Preoperative Care; Prognosis; Proto-Oncogene Proteins c-bcl-2 | 2007 |
Diabetes insipidus revealing an isolated pituitary stalk metastasis of breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cortisone; Cyclophosphamide; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Female; Fluorouracil; Humans; Hypopituitarism; Mastectomy, Modified Radical; Methotrexate; Pituitary Neoplasms; Radiotherapy, Conformal; Tamoxifen; Thyroxine | 2007 |
[Diagnosis and prognosis study of breast carcinoma with micropapillary component].
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Liver Neoplasms; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Tamoxifen | 2007 |
Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Keratins; Lymphatic Metastasis; Methotrexate; Middle Aged; Postmenopause; Premenopause; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Recurrence; Survival Analysis; Tamoxifen; Time Factors | 1994 |
Changes in Tc-99m radionuclide bone scan images and peripheralization of marrow hematopoietic activity associated with the administration of granulocyte colony stimulating factor as an adjunct to dose-intensified chemotherapy for breast cancer. A case rep
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Humans; Methotrexate; Radionuclide Imaging; Recurrence; Technetium | 1994 |
[Persistent granulocytosis and hyperuricemia after a single G-CSF injection (Filgrastim) in treatment of chemotherapy-induced myelosuppression in metastatic breast carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Injections, Subcutaneous; Leukocyte Count; Methotrexate; Radiotherapy, Adjuvant; Recombinant Proteins; Uric Acid | 1995 |
Breast cancer: are imaging studies cost effective following breast cancer and adjuvant therapy?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Cyclophosphamide; Diagnostic Imaging; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Mastectomy, Segmental; Methotrexate; Neoplasm Recurrence, Local; Treatment Outcome | 1995 |
[Treatment of carcinomatous meningitis by continuous intrathecal infusion of methotrexate: 2 cases].
Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Meningitis; Methotrexate; Middle Aged | 1995 |
Histologic grade of locally advanced infiltrating ductal carcinoma after treatment with induction chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Preoperative Care | 1994 |
Bilateral breast cancer in a male? Case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Fatal Outcome; Humans; Male; Mammography; Mastectomy, Modified Radical; Methotrexate; Neoplasm Recurrence, Local; Tamoxifen | 1993 |
Neoadjuvant chemotherapy in locally advanced breast cancer.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Mastectomy, Modified Radical; Mastectomy, Radical; Mastectomy, Segmental; Methotrexate; Nausea; Neoplasm Recurrence, Local; Vomiting | 1996 |
Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Estrogens, Conjugated (USP); Female; Fluorouracil; Humans; Mammography; Methotrexate; Middle Aged; Neoplasm, Residual; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tamoxifen | 1996 |
Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Feasibility Studies; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Remission Induction; Risk Factors; Survival Rate; Treatment Failure; Vincristine | 1995 |
Treatment of advanced breast cancer: How much chemotherapy is enough?
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lung Neoplasms; Mastectomy, Segmental; Methotrexate; Middle Aged; Paclitaxel; Tamoxifen | 1996 |
[A case of non-resectable pancreatic cancer surviving more than 4 years by intra-arterial infusion chemotherapy with angiotensin-II].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ductal, Breast; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Methotrexate; Middle Aged; Pancreatic Neoplasms; Survivors | 1996 |
[Combined breast-preserving surgery, chemotherapy and radiotherapy in the treatment of breast carcinoma. Effect of the interval between surgery and the beginning of radiotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Radiotherapy Dosage; Retrospective Studies; Time Factors | 1997 |
Continuous intrathecal perfusion of methotrexate for carcinomatous meningitis with pharmacokinetic studies: two case studies.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Injections, Spinal; Meningeal Neoplasms; Methotrexate | 1997 |
Ethics of randomized clinical trials.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplatin; Comprehension; Cyclophosphamide; Disclosure; Doxorubicin; Ethical Theory; Ethics, Medical; Female; Fluorouracil; Humans; Methotrexate; Paclitaxel; Patient Advocacy; Personal Autonomy; Physician-Patient Relations; Professional-Family Relations; Prognosis; Randomized Controlled Trials as Topic; Researcher-Subject Relations; Risk Assessment; Therapeutic Human Experimentation; Uncertainty | 1998 |
The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Estrogen Replacement Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Hyperplasia; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Precancerous Conditions; Radiotherapy Dosage; Survival Analysis | 1998 |
Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Doxorubicin; Fats; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoadjuvant Therapy; Nuclear Magnetic Resonance, Biomolecular; Water | 1998 |
Reduced expression of p27Kip1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclin-Dependent Kinase Inhibitor p27; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Mastectomy; Methotrexate; Microtubule-Associated Proteins; Middle Aged; Neoplasm Metastasis; Neoplasm Proteins; Ploidies; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Survival Analysis; Tumor Suppressor Proteins | 1999 |
[High-dose chemotherapy with autologous peripheral blood stem cell transplantation support in a patient with breast cancer metastasis to bone marrow: immunocytochemical monitoring of cancer-cell contamination].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunohistochemistry; Methotrexate; Transplantation, Autologous; Vinblastine | 1999 |
Treatment of mammographically detected minimal breast cancer in an older woman.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Mammography; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy; Tamoxifen | 2000 |
Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservation.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Decision Trees; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Methotrexate; Middle Aged; Prospective Studies; Remission Induction; Treatment Failure | 1999 |
Angiogenesis sustains tumor dormancy in patients with breast cancer treated with adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Methotrexate; Microcirculation; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Prognosis; Risk Factors | 2001 |
Management of inoperable carcinoma of the breast by curative radiotherapy and chemo-hormonotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Radiography; Radiotherapy, Adjuvant; Survival Rate | 2001 |
Prognostic value of thymidine phosphorylase expression in breast carcinoma.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Fluorouracil; Follow-Up Studies; Humans; Life Tables; Methotrexate; Neoplasm Invasiveness; Neoplasm Proteins; Neovascularization, Pathologic; Predictive Value of Tests; Prognosis; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen; Thymidine Phosphorylase | 2002 |
[Complicated antiphospholid antibody syndrome].
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiphospholipid Syndrome; Breast Neoplasms; Carcinoma, Ductal, Breast; Cerebral Infarction; Combined Modality Therapy; Cyclophosphamide; Diagnosis, Differential; Diagnostic Imaging; Female; Fluorouracil; Humans; Mastectomy, Segmental; Methotrexate; Middle Aged; Patient Care Team; Postoperative Complications; Pulmonary Embolism; Thrombophlebitis | 2002 |